Uveitis is not a common household word like glaucoma or macular degeneration — but according to the NEI, it causes 10–15% of all blindness in the developed world. It’s one of the few blinding eye conditions where early, aggressive treatment genuinely changes the outcome. The frustrating reality: many patients don’t recognize it, don’t see the right specialist quickly enough, or stop treatment too early because of cost.
Here’s what treatment actually costs at each stage — and where insurance picks up the tab.
What Uveitis Is
Uveitis is inflammation of the uveal tract — the pigmented, vascular middle layer of the eye comprising the iris, ciliary body, and choroid. Different anatomical locations mean very different treatment approaches and very different costs.
| Uveitis Type | Location | Typical Symptoms | Treatment Complexity |
|---|---|---|---|
| Anterior (iritis) | Iris and ciliary body | Eye pain, redness, photophobia, blurred vision | Usually manageable with drops |
| Intermediate | Vitreous, peripheral retina | Floaters, gradual blur, less pain | Periocular injections often needed |
| Posterior | Choroid and/or retina | Painless vision loss, floaters | Systemic treatment usually required |
| Panuveitis | All layers | Severe and variable | Most complex, highest cost |
Causes vary widely. About 50% of uveitis is idiopathic — no cause identified. Known causes include HLA-B27-associated conditions (ankylosing spondylitis, psoriatic arthritis, reactive arthritis), sarcoidosis, infectious causes (herpes simplex, toxoplasmosis, CMV, tuberculosis), and other autoimmune conditions. Identifying a cause matters because treatment of an infectious uveitis with corticosteroids alone can be dangerous — steroids suppress the immune response that’s fighting the infection.
Diagnostic Workup Costs
You need an ophthalmologist — not an optometrist alone, and definitely not urgent care. The initial evaluation includes a slit-lamp exam and dilated funduscopic evaluation. For new-onset uveitis, a systemic workup is usually recommended.
| Diagnostic Step | Cost Without Insurance |
|---|---|
| Ophthalmologist new patient visit | $200–$400 |
| OCT imaging | $75–$150 |
| Fluorescein angiography | $300–$600 |
| Lab workup (HLA-B27, ANA, RPR, ACE, IGRA) | $200–$500 |
| Chest imaging (rule out sarcoid, TB) | $100–$300 |
| Aqueous humor tap (infectious workup, rare) | $500–$1,500 |
The Treatment Ladder: What Each Level Costs
Level 1: Topical Corticosteroids ($50–$200/month)
Prednisolone acetate 1% is the standard front-line treatment for anterior uveitis. During an active flare, dosing often starts at every-hour frequency and tapers over 4–8 weeks.
- Prednisolone acetate 1% (generic): $30–$80 per bottle
- Difluprednate (Durezol — more potent, fewer doses needed): $80–$200 per bottle
- Cycloplegic/mydriatic drops (atropine, homatropine): $15–$50 — prevents iris scarring (posterior synechiae) and reduces ciliary spasm pain
A typical acute anterior uveitis flare, managed purely with drops, costs roughly $100–$300 total in medications plus the office visit.
Level 2: Periocular Injections ($300–$600 per injection)
When inflammation isn’t adequately controlled with drops — or when the location of inflammation (intermediate, posterior) can’t be reached topically — periocular steroid injections are the next step.
Triamcinolone acetonide injected into the sub-Tenon’s space is the most common approach. It’s an in-office procedure taking a few minutes. Effects last 4–8 weeks. Some patients need repeat injections.
Chronic, bilateral, or posterior uveitis often requires oral or systemic agents:
- Oral prednisone: $10–$40/month — effective short-term bridge, significant long-term side effects
- Methotrexate: $20–$100/month — requires monthly LFT monitoring; most commonly used steroid-sparing agent
- Mycophenolate mofetil (CellCept): $50–$200/month — effective for posterior uveitis; requires monitoring
- Cyclosporine: $100–$400/month — used for specific uveitis syndromes
- Adalimumab (Humira): $2,000–$5,000/month list price — FDA-approved for non-infectious uveitis in 2016; most patients with coverage pay $0–$100/month after prior authorization and copay assistance
Steroid-sparing agents require lab monitoring every 1–3 months — add $100–$300 in lab costs per monitoring cycle.
Level 3: Sustained-Release Implants ($5,000–$15,000)
For chronic, recurrent posterior uveitis that’s failed systemic therapy — or when systemic side effects are intolerable — sustained-release corticosteroid implants provide years of local drug delivery.
- Retisert (fluocinolone acetonide 0.59mg): Surgically implanted into the vitreous cavity. Releases steroid for approximately 3 years. Surgery cost: $8,000–$15,000 including facility and anesthesia fees. Insurance covers when medically indicated.
- Iluvien (fluocinolone acetonide 0.19mg): Smaller injectable implant, releases for up to 3 years. FDA-approved for diabetic macular edema; used off-label for uveitis in some cases.
- Ozurdex (dexamethasone implant): Biodegradable, injectable, lasts ~6 months. Cost: $1,500–$2,500 per injection. Useful for intermediate uveitis and recurrent anterior cases.
Seeing a Uveitis Specialist
Most general ophthalmologists can manage straightforward acute anterior uveitis. Complex, recurrent, posterior, or refractory cases need a uveitis subspecialist — a fellowship-trained ophthalmologist at a tertiary eye center or academic medical center. The AAO’s Preferred Practice Pattern for uveitis specifically recommends subspecialty referral for bilateral disease, posterior involvement, systemic associations, and treatment-refractory cases.
Subspecialty visits run $300–$500+ for new patient appointments at academic centers. Worth every dollar — undertreated uveitis causes secondary glaucoma, cataract, and macular edema, all of which require separate treatment at significant additional cost.
Uveitis recurs. Anterior uveitis flares return in roughly 40% of patients within 2 years. Learn the warning signs — unilateral eye pain, photophobia, redness without discharge, blurred vision — and see your ophthalmologist promptly when they appear. Early treatment of a flare prevents the cumulative structural damage that chronic inflammation causes. Don’t wait to see if a painful red eye “resolves on its own” when you have a known history of uveitis.
Bottom Line
Acute anterior uveitis managed with topical steroids runs $250–$600 total including office visits — mostly covered by medical insurance. Chronic, bilateral, or posterior uveitis requiring systemic immunosuppressants or surgical implants can cost $2,000–$15,000+ per year, but insurance covers severe cases when prior authorization is obtained. The NEI’s data is clear on what happens without treatment: 10–15% of all blindness in the US. The cost of adequate treatment is far lower than the cost of preventable vision loss.
Frequently Asked Questions
Uveitis is a medical condition, so it's billed to medical insurance — not vision plans. The ophthalmologist uses CMS-1500 medical claim forms, and standard deductibles and coinsurance apply. Biologic medications like adalimumab (Humira) require prior authorization but are typically covered for qualifying patients with documented refractory disease. Your vision plan (VSP, EyeMed) won't pay for uveitis care.
Very. The NEI reports that uveitis accounts for 10–15% of all blindness in the developed world. Untreated or undertreated inflammation damages the trabecular meshwork (causing secondary glaucoma), clouds the lens (causing cataract), and can cause cystoid macular edema — all of which permanently reduce vision. Prompt, aggressive treatment changes outcomes dramatically. Don't wait on a red, painful eye that's not conjunctivitis.
Anterior uveitis (iritis) is the most common form — it usually responds to topical corticosteroid drops and mydriatics, costing $60–$200 per flare plus office visits. Posterior and panuveitis are more severe — they can't be adequately treated with eye drops alone and typically require injections, systemic immunosuppressants, or implants. Posterior uveitis care can run $500–$5,000 per month in active disease, with costs extending years if the condition becomes chronic.